Rooibos for Bone Health

Research suggests that rooibos may support bone health through two complementary mechanisms: promoting bone formation by osteoblasts and inhibiting bone breakdown by osteoclasts, based on a small collection of laboratory studies conducted in cell models. Studies indicate that specific rooibos flavonoids such as orientin and luteolin can stimulate mineralization and alkaline phosphatase activity in human osteoblast cell lines, while rooibos extracts also appear to suppress osteoclast development and activity by interfering with NF-κB signaling, with fermented rooibos showing particularly strong inhibitory effects in mouse cell models. A comparative cell study further found that red rooibos promoted greater bone cell mineralization than white tea and performed comparably to or better than green and black teas, suggesting rooibos may be among the more promising tea varieties for bone-related research. All available evidence comes from in vitro laboratory studies, with no human clinical trials or animal studies yet published, and a 2024 methodological study highlights that polyphenol concentrations in rooibos tea degrade substantially over days, raising questions about consistency of exposure in future preclinical research — meaning these findings, while encouraging, cannot yet be translated into conclusions about effects in living organisms.